Ocuphire Pharma
zeta phase clinical trial in | Ocuphire Pharma
Company
Deck Type
Deck date
January 2022
Slide
27 of 114
Related slides by other companies
NeuroSense Therapeutics
Investor Presentation
June 2023
met primary exploratory positive clinical signal observed phase a trial with | NeuroSense Therapeutics
Mink Therapeutics
IPO
October 2021
phase clinical trial focused in acute | Mink Therapeutics
Arbutus Biopharma
Investor Presentation
August 2023
next generation oral | Arbutus Biopharma
Arbutus Biopharma
Investor Presentation
May 2023
next generation oral | Arbutus Biopharma
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
January 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights